LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 46 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,424,000 | -25.3% | 2,327,403 | 0.0% | 0.19% | -6.8% |
| Q1 2022 | $9,938,000 | -8.2% | 2,327,403 | -0.0% | 0.21% | +30.4% |
| Q4 2021 | $10,825,000 | +16.5% | 2,327,903 | 0.0% | 0.16% | +12.9% |
| Q3 2021 | $9,288,000 | -6.8% | 2,327,903 | 0.0% | 0.14% | -6.7% |
| Q2 2021 | $9,963,000 | +0.9% | 2,327,903 | 0.0% | 0.15% | -2.6% |
| Q1 2021 | $9,870,000 | +6.1% | 2,327,903 | -2.9% | 0.15% | -1.3% |
| Q4 2020 | $9,302,000 | -3.6% | 2,397,378 | +0.1% | 0.16% | -32.8% |
| Q3 2020 | $9,652,000 | -4.6% | 2,395,029 | +0.8% | 0.23% | -18.6% |
| Q2 2020 | $10,117,000 | +2.3% | 2,374,952 | +0.9% | 0.28% | -33.1% |
| Q1 2020 | $9,890,000 | +10.0% | 2,354,734 | +2.9% | 0.43% | +25.7% |
| Q4 2019 | $8,992,000 | -49.3% | 2,287,991 | +13.5% | 0.34% | -67.9% |
| Q3 2019 | $17,743,000 | -4.6% | 2,016,269 | +0.2% | 1.06% | +6.1% |
| Q2 2019 | $18,605,000 | +861.0% | 2,011,340 | +567.9% | 0.99% | +653.0% |
| Q1 2019 | $1,936,000 | -23.4% | 301,166 | +12.4% | 0.13% | -43.8% |
| Q4 2018 | $2,528,000 | -89.5% | 268,036 | -77.6% | 0.24% | -83.7% |
| Q3 2018 | $24,098,000 | -38.6% | 1,197,107 | -11.1% | 1.44% | -49.0% |
| Q2 2018 | $39,259,000 | +17.4% | 1,345,881 | +19.9% | 2.83% | -11.0% |
| Q1 2018 | $33,429,000 | -2.3% | 1,122,540 | +5.6% | 3.18% | -44.3% |
| Q4 2017 | $34,213,000 | -5.8% | 1,063,170 | +1.8% | 5.71% | -9.7% |
| Q3 2017 | $36,321,000 | +10.2% | 1,044,307 | -5.7% | 6.33% | -9.0% |
| Q2 2017 | $32,967,000 | +7.3% | 1,107,379 | +7.6% | 6.95% | -14.0% |
| Q1 2017 | $30,714,000 | +61.3% | 1,028,929 | -5.3% | 8.08% | +12.8% |
| Q4 2016 | $19,038,000 | -31.6% | 1,086,037 | -7.2% | 7.17% | -14.8% |
| Q3 2016 | $27,838,000 | +47.9% | 1,170,151 | -0.5% | 8.41% | +30.9% |
| Q2 2016 | $18,818,000 | -23.0% | 1,176,146 | +0.6% | 6.43% | -27.6% |
| Q1 2016 | $24,445,000 | -16.5% | 1,169,065 | +7.8% | 8.88% | -8.2% |
| Q4 2015 | $29,279,000 | -2.5% | 1,084,416 | +0.4% | 9.67% | +3.7% |
| Q3 2015 | $30,022,000 | +331.8% | 1,080,331 | +280.8% | 9.33% | +360.9% |
| Q2 2015 | $6,953,000 | -64.3% | 283,700 | -73.3% | 2.02% | -77.0% |
| Q1 2015 | $19,476,000 | -0.8% | 1,064,247 | 0.0% | 8.79% | +21.0% |
| Q4 2014 | $19,635,000 | – | 1,064,247 | – | 7.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
| RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
| Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
| Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
| Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
| P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
| Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
| Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
| EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |